These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10101569)

  • 1. A case report of heparin resistance due to acquired antithrombin III deficiency.
    Leong CK; Ong BC
    Ann Acad Med Singap; 1998 Nov; 27(6):877-9. PubMed ID: 10101569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation management in a patient with an acquired antithrombin III deficiency.
    Heller EL; Paul L
    J Extra Corpor Technol; 2001 Dec; 33(4):245-8. PubMed ID: 11806438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Heparin resistance during cardiopulmonary bypass].
    Maeda R; Fukuda H; Nakaigawa Y; Hiruta M; Hirabayashi Y; Seo N
    Masui; 2003 Sep; 52(9):1003-5. PubMed ID: 14531265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation Management and Heparin Resistance During Cardiopulmonary Bypass: A Survey of Society of Cardiovascular Anesthesiologists Members.
    Sniecinski RM; Bennett-Guerrero E; Shore-Lesserson L
    Anesth Analg; 2019 Aug; 129(2):e41-e44. PubMed ID: 30540616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there evidence that fresh frozen plasma is superior to antithrombin administration to treat heparin resistance in cardiac surgery?
    Beattie GW; Jeffrey RR
    Interact Cardiovasc Thorac Surg; 2014 Jan; 18(1):117-20. PubMed ID: 24014620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous use of argatroban and heparin during cardiopulmonary bypass.
    Okamura T; Shin'oka T; Ishibashi N; Ishii H; Kurosawa H
    Asian Cardiovasc Thorac Ann; 2010 Feb; 18(1):22-6. PubMed ID: 20124292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery.
    Lemmer JH; Despotis GJ
    J Thorac Cardiovasc Surg; 2002 Feb; 123(2):213-7. PubMed ID: 11828278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass.
    Nicholson SC; Keeling DM; Sinclair ME; Evans RD
    Br J Anaesth; 2001 Dec; 87(6):844-7. PubMed ID: 11878684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass.
    Shirota K; Watanabe T; Takagi Y; Ohara Y; Usui A; Yasuura K
    Artif Organs; 2000 Jan; 24(1):49-56. PubMed ID: 10677157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.
    Avidan MS; Levy JH; van Aken H; Feneck RO; Latimer RD; Ott E; Martin E; Birnbaum DE; Bonfiglio LJ; Kajdasz DK; Despotis GJ
    J Thorac Cardiovasc Surg; 2005 Jul; 130(1):107-13. PubMed ID: 15999048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating heparin resistance with antithrombin or fresh frozen plasma.
    Spiess BD
    Ann Thorac Surg; 2008 Jun; 85(6):2153-60. PubMed ID: 18498854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased concentration of antithrombin after preoperative therapeutic heparin does not cause heparin resistance during cardiopulmonary bypass.
    Linden MD; Schneider M; Baker S; Erber WN
    J Cardiothorac Vasc Anesth; 2004 Apr; 18(2):131-5. PubMed ID: 15073698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroperative effects of fresh frozen plasma and antithrombin III on heparin sensitivity and coagulation during nitroglycerine infusion in coronary artery bypass surgery.
    Kanbak M; Oc B; Salman MA; Ocal T; Oc M
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):593-9. PubMed ID: 21799398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heparin resistance and antithrombin deficiency].
    Maurin N
    Med Klin (Munich); 2009 Jun; 104(6):441-9. PubMed ID: 19533051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effect of fresh frozen plasma on the activated coagulation time in patients undergoing cardiopulmonary bypass.
    Barnette RE; Shupak RC; Pontius J; Rao AK
    Anesth Analg; 1988 Jan; 67(1):57-60. PubMed ID: 3257361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series.
    Chryssos A; Stroup SJ; Pifer MM; Tawil M; Conrad CG
    J Extra Corpor Technol; 2015 Mar; 47(1):44-7. PubMed ID: 26390679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of the anticoagulation regimen on endothelial-related coagulation in cardiac surgery patients.
    Boldt J; Schindler E; Welters I; Wittstock M; Stertmann WA; Hempelmann G
    Anaesthesia; 1995 Nov; 50(11):954-60. PubMed ID: 8678251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial antithrombin-III deficiency during cardiopulmonary bypass: a case report.
    Brinks HJ; Weerwind PW; Verkroost MW; Nováková I; Brouwer MH
    Perfusion; 2000 Nov; 15(6):553-6. PubMed ID: 11131221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.